RFA Clears Small Renal Cell Tumors
CT-guided percutaneous radiofrequency ablation (RFA) is safe and effective for treating small biopsy-proven renal tumors, according to researchers.
CT-guided percutaneous radiofrequency ablation (RFA) is safe and effective for treating small biopsy-proven renal tumors, according to researchers.
Topical glyceryl trinitrate (GTN) ointment is safe and effective in decreasing discomfort associated with transrectal ultrasonography (TRUS)-guided biopsy of the prostate, researchers conclude.
Prostate biopsies may be unwarranted in men aged 80 years and older and who have a PSA level of 30 ng/mL, according to investigators in the U.K.
Contrary to what is commonly thought, the risk of having a positive repeat prostate biopsy is no lower for men with a fluctuating PSA level than it is for those with a steady or steadily increasing PSA level.
ORLANDO—New findings presented here suggest clinicians should use a lower PSA velocity (PSAV) to recommend prostate biopsies in men who have PSA levels less than 4 ng/mL.
ORLANDO—A urine assay for prostate cancer gene 3 (PCA3) is superior to serum PSA tests for predicting outcomes of repeat prostate biopsy, data show.
Prostate cancer detection can be improved by pretreating men with dutasteride prior to biopsy guided by contrast-enhanced color Doppler (CECD) imaging, according to researchers.
WASHINGTON, D.C.—The best predictor of outcome in patients with lupus nephritis is kidney function at the time of renal biopsy, supporting the need for early diagnosis and treatment, researchers reported here at the American College of Rheumatology annual meeting.
Diagnostic gleason sums frequently differ from those determined by pathologic analysis of prostate biopsy specimens, a study shows. The discrepancies were due mostly to understaging.
MRI-guided biopsy of the prostate may improve the diagnostic accuracy in men with elevated or rising PSA levels following previous negative transrectal ultrasound (TRUS)-guided biopsies, German researchers report.